Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium

(2012) David C. Young et al.   PEDIATRIC PULMONOLOGY

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones

(2012) Chris Stockmann et al.   PEDIATRIC PULMONOLOGY

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins

(2012) Jeffery T. Zobell et al.   PEDIATRIC PULMONOLOGY

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems

(2012) Jeffery T. Zobell et al.   PEDIATRIC PULMONOLOGY

A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients

(2011) Jeffery T. Zobell et al.   PEDIATRIC PULMONOLOGY

Cystic Fibrosis Pulmonary Guidelines

(2009) Patrick A. Flume et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

(2009) J. Riethmueller et al.   INFECTION

A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis

(2009) Daniel J. Van Meter et al.   PEDIATRIC PULMONOLOGY

Case-control study of acute renal failure in patients with cystic fibrosis in the UK

(2008) A Smyth et al.   THORAX

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis – a population pharmacokinetic study

(2007) Stefanie Hennig et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY